A Study on Sirakambavatham

Kalaiarasi, R (2013) A Study on Sirakambavatham. Masters thesis, Government Siddha Medical College, Palayamkottai.


Download (5MB) | Preview


The clinical trial on sirakambavatham was choosen as the dissertation work to extend help in making the world of difference in the life of the patients and their families.Various literatures regarding sirakambavatham was collected in both siddha and modern aspects. The efficacy of the drug Vishnu chakara mathirai (internal), Vatha kesari thylam (external) is well established in the literature. Totally 45 cases were selected out of which 25 cases are in-patient,20cases are treated as out patient. Regarding the sex 28 were male patients and the remaining 17 were female patients. The patients were subjected to routine modern investigations. Detailed history and thorough examination was carried out in accordance to the proforma. Siddha investigations regarding ennvagai thervu, neer kuri, neikurri, mannikadai nool was recorded to every individual case. Routine investigations such as blood TC, DC, ESR, Hb. Urine albumin, suger, deposits are performed in each case. The detailed chemical analysis of the trial drug is done in the biochemical laboratory iof Government siddha medical college, palayamkottai. The drug Vishnu chakara mathirai indicates the presence of calcium, ferrous iorn. According to the pharmacological study, the drug is found to have anti inflammatory, analgesic, anti pyretic, anti spasmodic, anti convulsant and muscle relaxant activity. Vatha kesari thylam is found to have acute anti inflammatory action. Regarding toxicity studies, the drug does not indicate any signs of toxicity at different doses. The drug Vishnu chakara mathirai was subjected for heavy metal analysis and thin layer chromatography in IITchennai and found to have the all the perameters within the range. Based on the clinical sinario, On the whole of 45 cases, satisfactory improvement is observed in 26 cases (57.7%). 8 cases were reported to have moderate improvement (17.7%). Remaining 11 cases had the poor prognosis (24.4%). Based on the clinical futures drooling of the saliva was controlled in 31 cases, general nutrition and immunity was improved in 36 cases.improvement in motor activity was observed in 35 cases, bowel and bladder was regularized in 16 cases. CONCLUSION: Sirakambavatham which is an equalent entity to cerebral palsy is the most distressfull condition to the world of the patients, parents and their surroundings. Vatham acts as the king governing all the vital functions of the body, It’s the humour that ows its importance to the creature of the life, next come the Pitham responsible for the existence of life, and Kabham brings the end to the life. When Vatham (king) the force of creation itself get deranged at birth,Pitham( mandhiri) and Kapham(senapathi) also get deranged which is reflected as sirakambavatham. The trial drug is aimed to normalize the Vatham, which inturn stebilises the decreased pitham and normalize the increased kapham thus bringing the three humors static. On the whole, treatment with the trial drugs both internal and external along with the external therapies such as sudation, oliation, thookanam along with varmam manipulations, fomentation, vasthi, physical exercises, breathing exercises, and simple yoga techniques, in addition to motivation of the parents to improve the verbal and non verbal communications with the child brought the world of difference with good improvement in 60% of the cases. Hence I conclude that the trial drug Vishnu chakara mathirai and Vatha kesari thylam along with external therapies is effective in treating sirakambavatham for helping the child to attain his potential and lead an independent life.

Item Type: Thesis (Masters)
Uncontrolled Keywords: cerebral palsy ; Sirakambavatham ; Vishnu chakara mathirai ; Vatha kesari thylam.
Subjects: AYUSH > Kuzhanthai Maruthuvam
Depositing User: Kambaraman B
Date Deposited: 24 Apr 2018 14:21
Last Modified: 29 Dec 2018 16:05
URI: http://repository-tnmgrmu.ac.in/id/eprint/7272

Actions (login required)

View Item View Item